Shares of Avenue Supermarts (DMART) had a fireworks debut on the BSE, as it got listed at a share price of Rs 604.40, a 102.14% premium over its issue price offer of Rs. 299 per share.DMART is riding a wave of optimism on the stock markets and strong growth metrics. DMart's ratios have beaten industry averages - the firm's Return on Capital Employed (ROCE) was 10% for FY12-16 against the industry average for retailers of 5 per cent. The company's low price points have enabled it to post double digit revenue and net profit growth in the past FY. 

Divis Laboratories on the other hand, is having a bad news day today, with the share price of the company in a double-digit fall, and hitting a new 52 week low on news that the FDA has issued an Import Alert on the company's Unit II factory in Vishakapatnam. Unit 2 is Divis' largest production unit, accounting for 62% of products sold. The FDA's stringent move is consequently likely to hit company results. 

Stock in spotlight: Jubilant Life Sciences, whose fully owned subsidiary in Singapore, Jubilant Pharma Limited ('JPL'), is negotiating a potential acquisition of a specialty pharma business in the United States using only internal accruals. The proposed acquisition is a niche, profitable specialty pharma business which Jubilant says is "a strategic fit" for the company. Jubilant had hit a new 52 week high in the past few days. 

Photo of the day: A young elephant walks next to an adult in their enclosure in Cologne, Germany. Oliver Berg/dpa/AP